Twist Bioscience Competitors and Similar CompaniesClear all

Twist Bioscience's competitors and similar companies include Promega, Eurofins Genomics, Integrated DNA Technologies and GenScript.

	Twist Bioscience Twist Bioscience is a synthetic biology company that develops a proprietary silicon-based manufacturing process for the production of synthetic DNA.	Promega Promega is a company that provides life sciences solutions.	Eurofins Genomics Eurofins Genomics is a company specializing in the genomics industry.	Integrated DNA Technologies Integrated DNA Technologies (IDT) is a company that develops, manufactures, and markets nucleic acid products.	GenScript Genscript Biotech is a biotech company focusing on early drug discovery and development services.
Founding Date	Founding Date 2013	Founding Date 1978	Founding Date 1987	Founding Date 1987	Founding Date 2002
Type	Type Public	Type Private	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Technology biotech data storage drug development genetics life sciences platform	Tags Healthcare drug development life sciences	Tags Healthcare biotech clinical research genetics life sciences	Tags Healthcare bioengineering biotech life sciences pharma	Tags Technology biotech contractor drug development life sciences
Locations	Locations South San Francisco, US HQ Guangzhou, CN Tel Aviv, IL Hwaseong, KR Singapore, SG Carlsbad, US Quincy, US see more	Locations Madison, US HQ Alexandria, AU Sao Paulo, BR Beijing, CN Lyon, FR Walldorf, DE New Delhi, IN see more	Locations Luxembourg, LU HQ Toronto, CA Ebersberg, DE Bengaluru, IN Ota City, JP Louisville, US	Locations Coralville, US HQ Glen Waverley, AU Leuven, BE Shanghai, CN Tokyo, JP Hanam Si, KR Singapore, SG see more	Locations Nanjing, CN HQ Tokyo, JP Seoul, KR Rijswijk, NL Singapore, SG Oxford, GB Piscataway, US
Employees	Employees 979	Employees 1,947	Employees 562% decrease	Employees 1,7351% decrease	Employees 5,568
Financial
Revenue (est.)	Revenue (est.) $376.6m (FY, 2025)	Revenue (est.) $693m (Y, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $959.5m (FY, 2025)
Cost of goods	Cost of goods $185.6m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $332.3m (FY, 2025)
Gross profit	Gross profit $191m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $650.8m (FY, 2025)
Net income	Net income ($77.7m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income ($532.4m) (FY, 2025)
Operating ⚠
Countries	Countries N/A	Countries N/A	Countries N/A	Countries 100 (Apr, 2023)	Countries 100 (FY, 2022)
Trademarks (US)	Trademarks (US) N/A	Trademarks (US) 87 (Jul, 2024)	Trademarks (US) N/A	Trademarks (US) 38 (Apr, 2023)	Trademarks (US) N/A